CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoSTEFONI, VITTORIO
Pubblicazioni
Risultati 1 - 20 di 78 (tempo di esecuzione: 0.043 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 1 | 18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 1.01 Articolo in rivista | |
| 2 | 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. | Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. | 2006 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | |
| 3 | 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016 | CANCER MEDICINE | 1.01 Articolo in rivista | |
| 4 | A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008 | CANCER | 1.01 Articolo in rivista | |
| 5 | A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. | Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pe...llegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M. | 2008 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | |
| 6 | A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | |
| 7 | Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | |
| 8 | The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience | Marangon, Miriam; Tonialini, Lorenzo; Morigi, Alice; Stefoni, Vittorio; Broccoli, Alessandro; Pel...legrini, Cinzia; Casadei, Beatrice; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi | 2018 | AMERICAN JOURNAL OF HEMATOLOGY | 1.01 Articolo in rivista | |
| 9 | Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. | Broccoli A; Stefoni V; Faccioli L; Agostinelli C; Spinardi L; Pastore Trossello M; Zinzani P.L. | 2012 | RHEUMATOLOGY INTERNATIONAL | 1.01 Articolo in rivista | |
| 10 | Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013 | HEMATOLOGICAL ONCOLOGY | 1.01 Articolo in rivista | |
| 11 | BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia | Broccoli, Alessandro; Bertuzzi, Clara; Fiorentino, Michelangelo; Morigi, Alice; Stefoni, Vittorio...; Agostinelli, Claudio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi | 2019 | ONCOTARGETS AND THERAPY | 1.01 Articolo in rivista | |
| 12 | Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial | Zinzani, Pier Luigi; Pellegrini, Cinzia; Chiappella, Annalisa; Di Rocco, Alice; Salvi, Flavia; Ca...bras, Maria Giuseppina; Argnani, Lisa; Stefoni, Vittorio | 2017 | BLOOD | 1.01 Articolo in rivista | |
| 13 | Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS | Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, An...tonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi | 2020 | HAEMATOLOGICA | 1.01 Articolo in rivista | |
| 14 | A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies | Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani,... Lisa; Cavo, Michele; Zinzani, Pier Luigi | 2019 | HEMATOLOGICAL ONCOLOGY | 1.01 Articolo in rivista | |
| 15 | Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience | Stefoni, Vittorio; Broccoli, Alessandro; Argnani, Lisa; Sabattini, Elena; Cavo, Michele; Zinzani,... Pier Luigi | 2018 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1.01 Articolo in rivista | |
| 16 | Clinical significance of axillary findings in patients with lymphoma during follow up. C | . S. Tsamita, A. Golemi, V. Stefoni, P. Castellucci, M. Farsad, G. Montini, C. Nanni, C. Pellegri...ni, V. Ambrosini, D. Rubello, R. Franchi, P. Zinzani, S. Fanti; | 2007 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 4.02 Riassunto (Abstract) | |
| 17 | Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. | Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D....; Tani M.; Zinzani P.L.; Fanti S. | 2008 | NUCLEAR MEDICINE COMMUNICATIONS | 1.01 Articolo in rivista | |
| 18 | CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission. | Stefoni V; Broccoli A; Pellegrini C; Derenzini E; Fina M; Zinzani PL. | 2009 | JOURNAL OF NEURO-ONCOLOGY | 1.01 Articolo in rivista | |
| 19 | Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. | Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta ...MR; Narducci R; Argnani L; Zinzani PL. | 2013 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 1.01 Articolo in rivista | |
| 20 | Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. | Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argn...ani L.; Pileri S.; Baccarani M. | 2011 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1.01 Articolo in rivista |
Dettaglio
STEFONI, VITTORIO
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Ricercatori
STEFONI V; V. Stefoni
Copyright © 2020